Ensign Peak Advisors
AMED

Ensign Peak Advisors’s Amedisys AMED Stock Holding History

Ensign Peak Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-215,099
Closed -$15.8M – 1761
2023
Q1 		$15.8M Sell
215,099
-101,207
-32% -$8.76M 0.03% 321
2022
Q4 		$26.4M Sell
316,306
-251,801
-44% -$22.7M 0.06% 254
2022
Q3 		$55M Sell
568,107
-4,491
-0.8% -$536K 0.14% 140
2022
Q2 		$60.2M Buy
572,598
+357,598
+166% +$45.7M 0.14% 134
2022
Q1 		$37M Sell
215,000
-39,258
-15% -$5.87M 0.08% 205
2021
Q4 		$41.2M Sell
254,258
-17,184
-6% -$2.76M 0.08% 216
2021
Q3 		$40.5M Buy
271,442
+109,218
+67% +$22.7M 0.08% 198
2021
Q2 		$39.7M Buy
162,224
+88,374
+120% +$23.2M 0.08% 206
2021
Q1 		$19.6M Sell
73,850
-1,043
-1% -$294K 0.04% 317
2020
Q4 		$22M Buy
74,893
+11,147
+17% +$2.86M 0.05% 303
2020
Q3 		$15.1M Buy
63,746
+20,676
+48% +$4.7M 0.04% 366
2020
Q2 		$8.55M Buy
43,070
+3,500
+9% +$653K 0.02% 461
2020
Q1 		$7.26M Buy
39,570
+15,417
+64% +$2.74M 0.02% 418
2019
Q4 		$4.03M Buy
+24,153
New +$3.59M 0.01% 712

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Ensign Peak Advisors's AMED Position: Q2 2023 in Review

Ensign Peak Advisors sold out of Amedisys (AMED) in Q2 2023, closing a stake of 215,099 shares — an estimated $15.8M sold.

Ensign Peak Advisors first reported a position in AMED in Q4 2019 and held it in 14 quarters. The position peaked at $60.2M in Q2 2022. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

  • Ensign Peak Advisors reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
  • Ensign Peak Advisors sold 215,099 Amedisys shares in Q2 2023, an estimated $15.8M.
  • Ensign Peak Advisors first reported a position in Amedisys in Q4 2019 and held it in 14 quarters.
  • Ensign Peak Advisors's Amedisys position peaked at $60.2M in Q2 2022.
  • 301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.